A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.

Autor: Sklar, Marvin J.1 (AUTHOR), Maiolatesi, Santina1,2 (AUTHOR), Patterson, Noelle1,2 (AUTHOR), Sedegah, Martha1 (AUTHOR), Limbach, Keith1,2 (AUTHOR), Teneza-Mora, Nimfa1 (AUTHOR), Chuang, Ilin1 (AUTHOR), Hollis-Perry, K. Monique1 (AUTHOR), Banania, Jo Glenna1,2 (AUTHOR), Guzman, Ivelese1,2 (AUTHOR), Ganeshan, Harini1,2 (AUTHOR), Reyes, Sharina1,2 (AUTHOR), Hollingdale, Michael R.1,2 (AUTHOR) michael.r.hollingdale.ctr@mail.mil, Wong, Mimi1,2 (AUTHOR), Lindstrom, Ashley1 (AUTHOR), Reyes, Anatalio1,2 (AUTHOR), Alcorta, Yolanda1,2 (AUTHOR), Garver, Lindsey3 (AUTHOR), Bankard, Kelli1,2 (AUTHOR), Belmonte, Arnel1,2 (AUTHOR)
Zdroj: PLoS ONE. 9/8/2021, Vol. 16 Issue 9, p1-26. 26p.
Databáze: Academic Search Ultimate